CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED) (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Income Statement [Abstract]
Net Sales	$ 4,443	$ 5,434	$ 9,694	$ 10,445
Cost of products sold	1,245	1,481	2,548	2,824
Marketing, selling and administrative	1,004	1,040	2,006	1,968
Advertising and product promotion	224	253	418	467
Research and development	962	923	1,871	1,858
Provision for restructuring	20	40	42	84
Litigation expense/(recoveries)			(172)
Equity in net income of affiliates	(53)	(62)	(110)	(144)
Other (income)/expense	(18)	(31)	5	(169)
Total Expenses	3,384	3,644	6,608	6,888
Earnings Before Income Taxes	1,059	1,790	3,086	3,557
Provision for income taxes	251	483	796	883
Net Earnings	808	1,307	2,290	2,674
Net Earnings Attributable to Noncontrolling Interest	163	405	544	786
Net Earnings Attributable to Bristol-Myers Squibb Company	$ 645	$ 902	$ 1,746	$ 1,888
Earnings per Common Share Attributable to Bristol-Myers Squibb Company:
Basic	$ 0.38	$ 0.53	$ 1.04	$ 1.11
Diluted	$ 0.38	$ 0.52	$ 1.02	$ 1.10
Dividends declared per common share	$ 0.34	$ 0.33	$ 0.68	$ 0.66